The trajectory of companies tied to flagship drugs like Viagra presents a nuanced investment picture. While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the patent expiration in key territories has introduced significant uncertainty . Investors are now grappling with the effect of gener